Andrew Wakstein, DO
Otology & Neurotology · Palmerton, PANPI 1245292309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Aerin Medical Inc. at 24.1% of the total. 2025 is the largest year on record at $110, 2.5 times the $44 reported in 2019.
Across 18 payments — averaging $26.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$116
- Neurent Medical Limited$110
- Inspire Medical Systems, Inc.$43
- Sanofi$32
- Optinose US, Inc.$31
- Stryker$29
- plus $119 from 6 others
What the payments were for
- Food & beverage$479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 4 | $116 |
| Neurent Medical Limited | 3 | $110 |
| Inspire Medical Systems, Inc. | 1 | $43 |
| Sanofi | 1 | $32 |
| Optinose US, Inc. | 2 | $31 |
| Stryker | 1 | $29 |
| Axogen | 1 | $29 |
| Intersect ENT, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| GSK | 1 | $16 |
| Pfizer | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
How this compares
Too few otology & neurotology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 107 | $2,394 |
| Ofloxacin | 46 | $1,196 |
| Ipratropium Bromide | 34 | $873 |
| Azelastine Hcl | 13 | $570 |
| Famotidine | 27 | $469 |
| Montelukast Sodium | 21 | $391 |
| Mometasone Furoate | 16 | $354 |
| Prednisone | 32 | $97 |
| Mupirocin | 13 | $65 |
| Pantoprazole Sodium | 15 | $63 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Palmerton
- Eric HolenderPalmerton$2K
- Jacob HunterPhiladelphia$111K
- Todd HillmanPittsburgh$33K
- Tiffany HwaPhiladelphia$11K
- Ravi SamyBethlehem$6K
- Philip PerezPittsburgh$5K
- Abhinav EttyreddyWexford$3K
- Robert SataloffPhiladelphia$3K
- Gregory BasuraPittsburgh$2K
- Jacob McAfeePittsburgh$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.